Analysis of the structure of consumption of antiplatelet drugs in the Russian pharmaceutical market: 2014-2016

Качественная клиническая практика

S. K. Zyryanov¹  E. V. Dumchenko¹ 

[1] Peoples' Friendship University of Russia, Moscow, Russia;

关键词: исследование потребления лекарств;    обзор потребления лекарственных средств;    фармацевтический рынок;    антитромбоцитарные препараты;    тиклопидин;    клопидогрел;    тикагрелор;    россия;    drug utilization research;    survey of drug usage;    survey of drug consumption;    pharmaceutical market;    antiplatelet drugs;    ticlopidine;    clopidogrel;    ticagrelor;    russia;   

DOI  :  

来源: DOAJ

【 摘 要 】

This article analyzes the volume of the Russian pharmaceutical market of antiplatelet drugs in the period 2014-2016. 80% of patients take clopidogrel generics, giving preference to Zilt®. Among the original drugs, the leaders of consumption are Plavix® and Coplavix® - in 2016 year 16%. In the structure of consumption of antiplatelet drugs, the share of original drugs as a whole account for about 60% of consumption in value terms, which is about 25% in packs. Clopidogrel generics (54% in value terms and 85% in natural terms) pass through the state segment, which means that most of the original drugs are purchased by patients through the retail pharmacy network, despite their high cost.

【 授权许可】

Unknown